Alesse

   
Google
 
Web NewDrugInformation.com

Alesse


Drug - Alesse
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL-28
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ethinyl Estradiol; Levonorgestrel
Multiple ingredients are in alphabetical order.

Strength - 0.02MG;0.1MG
The potency of the active ingredient(s), Ethinyl Estradiol; Levonorgestrel. May repeat for multiple part products.

Applicant - WYETH PHARMS INC
The firm name holding legal responsibility for Alesse. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020683
The FDA assigned number to Alesse. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Alesse. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB1
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 27, 1997
The date Alesse was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Alesse. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Alesse is in. Format is RX, OTC, DISCN.

Applicant Full Name - Wyeth Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Alesse.

Alesse